REFERENCES
- Panchagnula, R. (1998). Pharmaceutical aspects of paclitaxel. International Journal of Pharmaceutics 172: 1–15.
- Sharma, A., Sharma, U.S., Straubinger, R.M. (1996). Paclitaxel-liposomes for intracavity therapy of intraperitoneal P388 leukemia. Cancer Lett 107: 265–272.
- Singla, A.K., Garg, A., Aggarwal, D. (2002). Paclitaxel and its formulations. International Journal of Pharmaceutics 235: 179–192.
- Rowinsky, E.K., Donehower, R.C. (1995). Paclitaxel (taxol). The New England Journal of Medicine 332: 1004–1014.
- Zhang, G.J.A., Ma, L., Ugwu, S., Xuan, T., Sardone, T., Ahmad, I. (2005). Development and characterization of a novel Cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation. European Journal of Pharmaceutics and Biopharmaceutics 59: 177–187.
- Allen, T.M. (1998). Liposomal drug formulations. Rationale for development and what we can expect for the future. Drugs 56: 747–756.
- Drummond, D.C., O. Meyer, K. Hong, D.B. Kirpotin, D. Papahadjopoulos. (1999). Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacological Reviews 51: 691–743.
- Tilcock, C. (1999). Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound. Advanced Drug Delivery Reviews 37: 33–51.
- Webb, M.S., D. Saxon, F.M. Wong, H.J. Lim, Z. Wang, M.B. Bally, L.S. Choi, P.R. Cullis, L.D. Mayer. (1998). Comparison of different hydrophobic anchors conjugated to poly (ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochimica et Biophysica Acta 1372: 272–282.
- Kono, K., K. Zenitani, T. Takagishi. (1994). Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups. Biochimica et Biophysica Acta 1193: 1–9.
- Woodle, M.C. (1998). Controlling liposome blood clearance by surface-grafted polymers. Advanced Drug Delivery Reviews 32: 139–152.
- Moreira, R.G.J.N., T.M. Allen (2001). Targeting stealth liposomes in a mutine model of human small cell lung cancer. Biochim. Biophys. Acta 1515: 167–176.
- Torchilin, A.A.K.A.V.P. (2007). “Smart” drug carriers: PEGylated TATp-modified pH-sensitive liposome. Journal of Liposome Research 17: 197–203.
- Shin, J., P. Shum, D.H. Thompson (2003). Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J Control Release 91: 187–200.
- Maeda, N., Y. Takeuchi, M. Takada, Y. Sadzuka, Y. Namba, N. Oku (2004). Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome. J Control Release 100: 41–52.
- Xu, W.W.G.Z.H., J. Huang, H. Sui, Z.H. Zhou, Y.X. Yang, Z. Yan, Y.P. Li (2005). In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int. J. Pharm. 288: 361–368.
- Zhang, C., Yu, L.L., Ping, Q. (2007). Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives. Colloids Surf B Biointerfaces 55: 192–199.
- Zhang, C., Sun, Y., Wu, X., Yao, Z., Guo, Q., Ding, Q., Yuan, S., Shen, Z., Ping, Q., Zhou, H. (2008). Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials 29: 1233–1241.
- Jung, S.H., H. Seong, S.H. Cho, K.S. Jeong, B.C. Shin (2009). Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity. International Journal of Pharmaceutics 382: 254–261.
- Kajiwara, E., K. Kawano, Y. Hattori, M. Fukushima, K. Hayashi, Y. Maitani (2007). Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy. J Control Release 120: 104–110.